Back
Edwards Lifesciences Quote, Financials, Valuation and Earnings
Sponsored
EW
Sponsored
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!
Sell
38
EW
Edwards Lifesciences
Last Price:
86.46
Seasonality Move:
8.36%
7 Day Trial
ALL ACCESS PASS
$
7
America's Final Republican President
Click here to see his 2024 election prediction.Edwards Lifesciences Price Quote
$86.46
+0.03 (+-1.76%)
(Updated: April 27, 2024 at 6:03 AM ET)
Edwards Lifesciences Key Stats
Sell
38
Edwards Lifesciences (EW)
is a Sell
Day range:
$84.71 - $88.38
52-week range:
$60.57 - $96.12
Dividend yield:
0%
P/E ratio:
37.58
P/S ratio:
8.77
P/B ratio:
7.82%
Volume:
5M
Avg. volume:
3.3M
1-year change:
-1.12%
Market cap:
$52B
Revenue:
$6B
EPS:
$2.3
How Much Does Edwards Lifesciences Make?
-
How Much Are Edwards Lifesciences's Sales Annually?
EW Revenues are $6B -
How Much Profit Does Edwards Lifesciences's Make A Year?
EW net income is $1.4B
Is Edwards Lifesciences Growing As A Company?
-
What Is Edwards Lifesciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.14% -
What Is Edwards Lifesciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.06%
Edwards Lifesciences Stock Price Performance
-
Did Edwards Lifesciences Stock Go Up Last Month?
Edwards Lifesciences share price went down by -7.48% last month -
Did EW's Share Price Rise Over The Last Year?
EW share price fell by -1.12% over the past 1 year
What Is Edwards Lifesciences 52-Week High & Low?
-
What Is Edwards Lifesciences’s 52-Week High Share Price?
Edwards Lifesciences has traded as high as $96.12 over the past 52 weeks -
What Is Edwards Lifesciences’s 52-Week Low Share Price?
Edwards Lifesciences has traded as low as $60.57 over the past 52 weeks
Edwards Lifesciences Price To Free Cash Flow
-
Is Edwards Lifesciences Stock Overvalued?
Edwards Lifesciences is trading at a price to free cash flow ratio of 83.67 -
Is Edwards Lifesciences Stock Undervalued?
Edwards Lifesciences EV to Free Cash Flow ratio is 81.00 -
What Is Edwards Lifesciences’s Price Earnings Growth Ratio?
EW PEG ratio is 0.00 -
Is Edwards Lifesciences Trading At A Premium To Earnings?
Edwards Lifesciences EV to EBIT ratio is 31.56
Is It Risky To Buy Edwards Lifesciences?
-
How Much Debt Does Edwards Lifesciences Have?
Total long term debt quarterly is $597M -
How Much Cash Does Edwards Lifesciences Have?
Cash and short term investments quarterly total is $1.6B -
What Is Edwards Lifesciences’s Book Value Per Share?
Book value per share is 11.06
Is Edwards Lifesciences Cash Flow Positive?
-
What Is EW Cash Flow From Operations?
Cash flow from operations (TTM) is $895.8M -
What Is Edwards Lifesciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$711M -
What Is Edwards Lifesciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is $173.8M
Edwards Lifesciences Return On Invested Capital
-
Is Management Doing A Good Job?
EW return on invested capital is 20.18% -
What Is Edwards Lifesciences Return On Assets?
ROA measures how assets are converting to revenues and is 15.69% -
What Is EW Return On Equity?
ROE is a measure of profitability and is 22.08%
Edwards Lifesciences Earnings Date & Stock Price
-
What Is Edwards Lifesciences's Stock Price Today?
A single share of EW can be purchased today for 86.43 -
What Is Edwards Lifesciences’s Stock Symbol?
Edwards Lifesciences trades on the S&P500 under the ticker symbol: EW -
When Is Edwards Lifesciences’s Next Earnings Date?
The next quarterly earnings date for Edwards Lifesciences is scheduled on July 26, 2024 -
When Is EW's next ex-dividend date?
Edwards Lifesciences's next ex-dividend date is April 27, 2024 -
How To Buy Edwards Lifesciences Stock?
You can buy Edwards Lifesciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Edwards Lifesciences Competitors
-
Who Are Edwards Lifesciences's Competitors?
Below is a list of companies who compete with Edwards Lifesciences or are related in some way:
Edwards Lifesciences Dividend Yield
Data Unavailable
Edwards Lifesciences Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -6.15% | 2.79% |
Revenue: | 13.78% | 1.68% |
Analyst Recommendations
Buy Recommendations: | 11 |
---|---|
Hold Recommendations: | 15 |
Sell Recommendations: | 1 |
Price Target: | 94.66 |
Upside from Last Price: | 9.52% |